<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.iongenomics.bio/p/illumina-pays-standard-biotools-30m</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-28T17:57:53+00:00</news:publication_date><news:title>Standard BioTools Gets $30M Illumina Buyout Ahead of Treeline Merger</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/lucid-genomics-genetic-alliance-partner</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-28T17:51:42+00:00</news:publication_date><news:title>Lucid Genomics, Genetic Alliance Partner on Access to Rare Disease Analysis Software</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/fda-approves-freenomes-simplescreen</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-27T21:55:45+00:00</news:publication_date><news:title>FDA Approves Freenome's SimpleScreen CRC Blood Test</news:title></news:news></url></urlset>